Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczema

Pfizer's Cibinqo snags FDA approval to challenge Sanofi and Regeneron's Dupixent in eczemaesagonowskyFri, 01/14/2022 - 15:56